We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $43.2 · 20 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Fact Check: Moderna's 2023 Vaccine Research Does Not Prove Hantavirus Was Engineered for Profit - Tempo.co English
Fact Check: Moderna's 2023 Vaccine Research Does Not Prove Hantavirus Was Engineered for Profit Tempo.co English
Wing Commander Opening (1999) Moderna Stock (UjsZflydmQ) - Mshale
Wing Commander Opening (1999) Moderna Stock (UjsZflydmQ) Mshale
Moderna (MRNA) CFO vests RSUs and withholds 533 shares to cover taxes - Stock Titan
Moderna (MRNA) CFO vests RSUs and withholds 533 shares to cover taxes Stock Titan
Moderna (MRNA) Chief Legal Officer reports RSU vesting and tax-share withholdings - Stock Titan
Moderna (MRNA) Chief Legal Officer reports RSU vesting and tax-share withholdings Stock Titan
Moderna (MRNA) president logs RSU vesting and tax-withholding share dispositions - Stock Titan
Moderna (MRNA) president logs RSU vesting and tax-withholding share dispositions Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 31. | After market close (AMC) | $-2 | — | — | $101.77M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-2.52 | — | — | $108M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-6.37 | — | — | $2.27B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-6.41 | — | — | $408M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 05. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 05. 05. | Goldman Sachs | — | Maintain | Neutral → Neutral | — | Goldman Sachs: Neutral |
| 2026. 05. 05. | Evercore ISI Group | — | Maintain | In-Line → In-Line | — | Evercore ISI Group: In-Line |
| 2026. 05. 05. | RBC Capital | — | Maintain | Sector Perform → Sector Perform | — | RBC Capital: Sector Perform |
| 2026. 04. 02. | Barclays | — | Maintain | Equal-Weight → Equal-Weight | — | Barclays: Equal-Weight |
| 2026. 02. 23. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 9,086,404 | $461.59B | 0.39% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 7,342,096 | $216.52B | 0.34% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 197,844 | $10.05B | 0.02% | — | New position |